CMS has advised Austria’s Alpla on its acquisition of Polish pharmaceutical packaging producer Apon.
Alpla specializes in plastic packaging solutions, producing packaging systems, bottles, caps, and injection-molded parts for a range of industries.
According to CMS, Alpla is “strengthening the presence of its pharmaceutical division in Central and Eastern Europe following the acquisition of the Polish company Apon. Apon was founded in 1985 as a family business. Today, around 45 employees produce plastic packaging for the pharmaceutical industry at the Zyrardow site near Warsaw. Among other things, Apon manufactures primary packaging for medicines in accordance with ISO 15378 under clean room conditions.”
Earlier this year, CMS advised Alpla on its investment in Swedish start-up Blue Ocean Closures (as reported by CEE Legal Matters on January 11, 2022). In 2021, CMS advised Alpla on a joint venture with Ecohelp and UPT (as reported on October 14, 2021) and its acquisition of the Wolf Plastics Group (as reported on October 27, 2021).
The CMS team included Vienna-based Partner Alexander Rakosi, Associates Marie-Christine Lidl and Anna Hiegelsperger, and Lawyer Dieter Zandler, and Warsaw-based Partner Blazej Zagorski, Senior Associates Joanna Bialoskorska, Maciej Olejnik, and Maciej Andrzejewski, Associates Kinga Mogilnicka and Karolina Terech, and Lawyers Aleksandra Dalecka, Tomasz Piotrowski, Michal Serwa, Agnieszka Gorecka, Marta Trebacka, and Katarzyna Los.
CMS did not respond to our inquiry on the matter.